Discussion

Abstract

Get full access to this article

View all access options for this article.

References

Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 1998; 351: 1451—67

International Breast Cancer Study Group. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. J Clin Oncol 2006; 24: 1332—41.

Cortazar P. , Johnson BE Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 1999; 17: 1625—31.

Schilsky RL Target practice: oncology drug development in the era of genomic medicine . Clinical Trials 2007; 4: 160—63.

Siegel JP Developing targeted therapy. Clinical Trials 2007; 4: 167—69.

Simon R. New challenges for 21st century clinical trials. Clinical Trials 2007; 4: 164—66.

Temple R. , Stockbridge NL BiDil for heart failure in black patients: the U.S. Food and Drug Administration perspective. Ann Intern Med 2007; 146: 57—62.